Candriam SCA’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-934,551
Closed -$15.3M 923
2021
Q2
$15.3M Buy
934,551
+540,263
+137% +$8.87M 0.11% 226
2021
Q1
$11.7M Buy
394,288
+6
+0% +$178 0.1% 227
2020
Q4
$12.2M Buy
+394,282
New +$12.2M 0.1% 231